-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Larimar Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2023.
- Larimar Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.77M, a 117% increase year-over-year.
- Larimar Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $8.99M, a 93.1% increase year-over-year.
- Larimar Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $4.81M, a 311% increase from 2022.
- Larimar Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.17M.
- Larimar Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$171K, a 153% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)